Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SISCA: Early Invasive Strategy with Tirofiban in NSTE-ACS
NCT00445263Phase 4Terminated
- Sponsor
- Hôpital Avicenne
- Start
- Mar 2007
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tirofiban in Non-ST-elevation acute coronary syndrome (NSTE-ACS), sponsored by Hôpital Avicenne. Started Mar 2007; status: terminated.
02
Drugs
tirofiban
03
Conditions
Non-ST-elevation acute coronary syndrome (NSTE-ACS)
Beyond the preview
Go deeper on NCT00445263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00445263.